Successful treatment of aluminium encephalopathy by intraperitoneal desferrioxamine.
D000535:Aluminum / Q000009:adverse effects*; D001927:Brain Diseases / Q000139:chemically induced / Q000188:drug therapy*; D003676:Deferoxamine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007274:Injections, Intraperitoneal; D008875:Middle Aged; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*
D000535:Aluminum; D003676:Deferoxamine